UroGen Pharma Ltd. Income Statement

Income Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 17.53M8.16M1.13M0.02M11.80M48.04M64.36M82.71M90.40M
Cost of Revenue 0.03M0.60M1.80M1.01M5.16M7.65M9.36M8.88M
Gross Profit 17.50M7.56M-0.68M0.02M10.79M42.88M56.70M73.35M81.52M
Operating items
Research & Development 10.52M10.29M18.70M36.93M49.30M47.31M47.64M52.91M45.61M57.15M
Selling, General & Administrative 1.90M6.42M8.81M39.57M60.20M90.22M87.53M82.84M93.27M121.15M
Operating Expenses 12.41M16.70M27.51M76.50M109.50M137.53M135.18M135.74M138.89M178.30M
Operating Income -12.41M0.80M-19.95M-77.18M-109.48M-126.74M-92.29M-79.04M-65.54M-96.78M
EBIT -12.41M0.80M-19.95M-77.18M-109.48M-126.74M-92.29M-79.04M-65.54M-96.78M
Non-operating items
Interest & Investment Income 1.99M0.36M1.01M3.48M8.67M
Other Non Operating Income 0.01M-0.12M2.08M1.44M1.05M5.70M6.93M
Non Operating Income -0.28M-2.74M0.01M-0.12M0.02M0.02M-0.15M-0.26M-0.69M-0.67M
Net income details
EBT -12.69M-1.94M-19.98M-75.53M-105.15M-125.11M-109.37M-108.03M-98.32M-124.04M
Tax Provisions 0.02M0.12M3.37M1.45M1.75M3.92M2.83M
Profit After Tax -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Income from Continuing Operations -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Consolidated Net Income -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Income towards Parent Company -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Net Income towards Common Stockholders -12.69M-1.94M-20.00M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M-126.87M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M
Shares Outstanding (Weighted Average) 13.01M13.01M13.75M20.98M22.09M22.42M23.09M30.87M42.20M
Shares Outstanding (Diluted Average) 8.29M13.61M
EBITDA -12.41M0.80M-20.00M-75.66M-104.87M-128.49M-111.12M-109.86M-102.12M-126.83M